Antabuse in Severe Alcoholism: an Open Controlled Study
NCT ID: NCT00431262
Last Updated: 2007-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2007-02-28
2009-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Promoting Medications for Alcohol Use Disorder on the General Medicine Service
NCT04287790
A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram
NCT03543735
Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
NCT00435435
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
NCT04101227
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment Outcome
NCT03818191
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
antabuse (disulfiram)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Living in the departments catchment area
Exclusion Criteria
* Schizophrenia
* Bipolar disorder
* Other substance abuse
* Dementia
* Anorexia
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Psykiatrisk Center Gentofte
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jakob Ulrichsen, MD, ph.d.
Role: PRINCIPAL_INVESTIGATOR
Psykiatrisk Center Gentofte
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Psykiatrisk Center Gentofte
Hellerup, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EudraCT no. 2006-004921-27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.